Compound Preferred

Vendor Details

Compound Preferred is a dynamic solution-driven 503B outsourcing facility dedicated to providing high-quality, compliant pharmaceutical products to the medical community. They value quality and customer safety above all other aspects around production which is why they complete thorough third-party testing to ensure confidence in their quality solutions. Unlike 503A pharmacies, Compound Preferred follows stringent FDA regulations and cGMP guidelines to ensure Members’ liability and their patients’ safety. Their dedication to customer service, competitive prices, and quality assurance set them apart from other compounding facilities. Now, MedResults Members have access to quarterly rebates on all Compound Preferred purchases.

The MRN-Compound Preferred partnership will be rolled out with a phased approach. Phase I initiated on October 1, 2021, will serve more than 300 Members in UT, ID, MT, WA, CO, OR, MI and GA. Phase Two will occur in early 2022, servicing Members in CA and several other high-density states.  The final phase will occur late 2022/early 2023 and include most remaining states.

For more information about Compound Preferred and 503B Outsourcing Facilities, you may visit their site here:

  • MedResults Member Information

  • This field is for validation purposes and should be left unchanged.